Patient tolerance during rigid cystoscopy: An observational study comparing lignocaine hydrochloride gel and tramadol with lignocaine

In the field of urology, cystoscopy is one of the most common operations. A rigid cystoscope was used for each cystoscopy in this investigation. Given its dual function as a lubricant and local anesthetic, topical lignocaine gel is the most often utilized agent. However, there is currently no established protocol that evaluates the patient's tolerance to lignocaine gel alone or in conjunction with tramadol throughout the treatment. It was a prospective comparative observational study with 200 male participants, conducted at the department of urology, a tertiary care hospital. Male patients who came for rigid cystoscopy were divided into 2 groups. In Group A (n = 100) 10 ml 2% lignocaine gel and in group B (n = 100) 1 ml tramadol (50 mg) solution added to +10 ml 2% lignocaine gel and it was instilled transurethrally 10 min before the procedure respectively in both groups at room temperature. The patient's tolerance during the procedure was assessed using Visual Analog Score (VAS) score. In Group A and Group B there was no significant difference between the groups in terms of age (p = 0.393). There was a significant difference in terms of VAS score (p = < 0.001), with the median Score being lower in the Lignocaine gel + tramadol group and higher when lignocaine gel + tramadol used among patients with Diabetes mellitus. The instillation of lignocaine gel in conjunction with tramadol in urethra could decrease pain perception during the procedure except in people with diabetes mellitus, hence make men undergoing rigid cystoscopy more comfortable during the procedure there by increase diagnostic and therapeutic outcome.